Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
biOasis Technologies Ord Shs
BIOAF
Primary Symbol:
V.BTI.H
Healthcare
Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in...
particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:BTI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(4)
•••
DeadMonkey
X
View Profile
View Bullboard History
Comment by
DeadMonkey
on May 04, 2023 11:39am
RE:RE:RE:RE:My How Time Flies When You Are Having Fun!
ever wrote that xb3 didnt work or was an issue. it is quite the contrary. you may have asked but it has been clear over the years that they were not alawys honest with you. you have no idea what
...more
(4)
•••
DeadMonkey
X
View Profile
View Bullboard History
Comment by
DeadMonkey
on May 04, 2023 11:30am
RE:Prothena
you so sure about that? 100% certain? drug companies make improvements to their drugs all of the time.largely goes unnoticed by most except those paying close attention to patents, just because they
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on May 04, 2023 11:27am
RE:RE:Monkeys
I understand your argument, DM. Why was there never any penetration information released? jd
(4)
•••
DeadMonkey
X
View Profile
View Bullboard History
Comment by
DeadMonkey
on May 04, 2023 11:25am
RE:Monkeys
your comment is short-sighted.-the study was done in healthy animals on purpose. it showed xb3 crossed bbb in nhp's validating all of the rodent stufies. showing it is capable of doing so.there is
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on May 04, 2023 11:04am
Prothena
Best to be careful when considering any success Prothena might have with PRX012. That drug preceded the Prothena/Bioasis deal and is not an xB3 drug. Prothena has never announced what it is or was
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on May 04, 2023 10:49am
RE:RE:RE:My How Time Flies When You Are Having Fun!
Let's be a little careful, DeadMonkey. J&J was around since RH's days but there were no formal deals that were material. Tire-kicking isn't really a deal. Material Transfer Agreements
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on May 04, 2023 10:42am
Monkeys
The Bioasis study with non-human primates back in 2018 DID NOT show that xB3-001 works in monkeys. It was a silly study because the monkeys had no health issues, such as brain tumours. It was
...more
(4)
•••
DeadMonkey
X
View Profile
View Bullboard History
Comment by
DeadMonkey
on May 04, 2023 10:20am
RE:RE:My How Time Flies When You Are Having Fun!
do you realize that BTI had a deal with J&J long before DR was ever there? DR and current BOD have contributed NOTHING. only taken credit for other people's work.
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on May 04, 2023 10:08am
Question for prophetoffactz...
Can you explain to us, poof, how RNAi might compete with the transport of existing therapies like Herceptin (xB3-001), IL-1Ra (xB3-004), and other biologics across the BBB? You have an
...more
(4)
•••
DeadMonkey
X
View Profile
View Bullboard History
Comment by
DeadMonkey
on May 04, 2023 10:05am
RE:RE:RE:RNAi
A non-human primate study was conducted under MD and XB3 was shown to work in monkeys - it crossed the bloodbrainbarrier and penetrated the lymph system.it works. why do you think prothena's drug
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on May 04, 2023 10:05am
RE:RE:Non-human primate testing
Can you explain to us, poof, how RNAi might compete with the transport of existing therapies like Herceptin (xB3-001), IL-1Ra (xB3-004), and other biologics across the BBB? You have an irresponsible
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on May 04, 2023 9:14am
RE:Non-human primate testing
This guy ran the largest RNAi company and is saying the RNAi gold rush for the CNS is on.
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 04, 2023 9:08am
Non-human primate testing
@JMaraganore
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 03, 2023 4:29pm
PLX up ahead of conference call tomorrow
$3.150.51 | 19.32%R If they ever wanted to buy BTI if they paid C$40 million for it it would only mean 16.4% more shares now. It's up over 200% in the last six months. Prothena
...more
(302)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on May 03, 2023 4:06pm
RE:RE:RE:RE:RNAi
November 2018! Hard to believe we never advanced in all these years! HUGE disconnect for sure!
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.